Stocks
Vaccinex, Inc.VCNX
PNKHealthcareBiotechnology$0.90
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for neurological and autoimmune diseases, with its lead candidate, intuniv, targeting Huntington's disease and other CNS disorders. Investors track VCNX for its proprietary SIGLEC platform and upcoming clinical trial readouts that could determine its path to commercialization.
52W Range: $0.31-$1.50
Congressional Interest in Vaccinex, Inc. (VCNX)
No congressional trades have been disclosed for Vaccinex, Inc. (VCNX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VCNX?
No congressional trades found for this stock.